Anti-cancer chemotherapeutic agents such as gemcitabine and 5-fluorouracil, induced activation of the NLRP3 inflammasome, which was dependent on lysosomal permeabilization and the release of cathepsin B, while this activation in myeloid-derived suppressor cells blunted their anticancer efficacy (49). This evidence concerns the gene NLRP3 and cancer.